Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines.

Joffe, Steven

Joffe, Steven.

Joffe S; Department of Medical Ethics and Health Policy, University of Pennsylvania Perelman School of Medicine, Philadelphia.

JAMA ; 325(3): 221-222, 2021 01 19.

Article in English | MEDLINE | ID: covidwho-1086205

Subject(s)

COVID-19 Vaccines/therapeutic use; COVID-19/prevention & control; Drug Approval/methods; Randomized Controlled Trials as Topic; SARS-CoV-2/immunology; COVID-19/epidemiology; Humans; Incidence; Investigational New Drug Application; Placebos/therapeutic use; Randomized Controlled Trials as Topic/ethics; Randomized Controlled Trials as Topic/methods; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Randomized Controlled Trials as Topic / Drug Approval / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: JAMA Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google